Characterization of the immune profile of oral tongue squamous cell carcinomas with advancing disease
Oral tongue squamous cell carcinomas (OTSCC) exhibit primary immune failure to control carcinogenesis demonstrated by the absence of an immune response to the development of nodal metastases or recurrent disease. Proinflammatory immune gene expression is counteracted by immunosuppressive signaling mediated by FOXP3 and PD ‐L1 expression. A gene signature was identified that was not prognostic in HNSCC but was significantly associated with survival in other cancers, demonstrating histotype‐dependent prognostic effects of immune regulation. AbstractWe investigated whether a unique immune response was instigated with the development of oral tongue squamous cell carcinomas (OTSCC), with/without nodal involvement, with/without recurrent metastatic disease, or within tumor involved nodes. One hundred and ten formalin ‐fixed paraffin‐embedded samples were collected from a retrospective cohort of 67 OTSCC patients and 10 non‐cancerous tongue samples. Targets including CD4, CD8, FOXP3, PD‐L1, and PD‐1 were analyzed by immunohistochemistry. The Nanostring PanCancer Immune Profiling Panel was used for gene expression profiling. Data were externally validated in the The Cancer Genome Atlas (TCGA) head and neck (HNSCC), melanoma and lung squamous cell carcinoma (LSCC) cohorts. A 24‐immune gene signature was identified that discriminated more aggressive OTSCC cases, and although not prognostic in HNSCC was associated with survival in other TCGA cohorts (improved survival fo...
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Katie Meehan,
Connull Leslie,
Michaela Lucas,
Angela Jacques,
Bob Mirzai,
James Lim,
Max Bulsara,
Yasir Khan,
Nicholas C. Wong,
Benjamin Solomon,
Chady Sader,
Peter Friedland,
Gisela Mir Arnau,
Timothy Semple,
Annette M. Lim Tags: ORIGINAL RESEARCH Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Genetics | Head and Neck Cancer | HNSCC | Melanoma | Nanotechnology | Oral Cancer | Skin Cancer | Squamous Cell Carcinoma